Literature DB >> 33663011

Concomitant neurodegenerative pathologies contribute to the transition from mild cognitive impairment to dementia.

Kirsty E McAleese1, Sean J Colloby1, Alan J Thomas1, Safa Al-Sarraj2, Olaf Ansorge3, James Neal4, Federico Roncaroli5, Seth Love6, Paul T Francis2,7, Johannes Attems1.   

Abstract

INTRODUCTION: The aged brain frequently exhibits multiple pathologies, rather than a single hallmark pathology (pure pathology [PurP]), ranging from low/intermediate levels of additional pathology (LowP) to mixed severe pathology (mixed SevP). We investigated the frequency of PurP, LowP, and mixed SevP, and the impact of additional LowP on cognition.
METHODS: Data came from 670 cases from the Brains for Dementia research program. Cases were categorized into PurP, mixed SevP, or a main disease with additional LowP; 508 cases had a clinical dementia rating.
RESULTS: 69.9% of cases had LowP, 22.7% had PurP, and 7.5% had mixed SevP. Additional LowP increased the likelihood of having mild dementia versus mild cognitive impairment (MCI) by almost 20-fold (odds ratio = 19.5). DISCUSSION: Most aged individuals have multiple brain pathologies. The presence of one additional LowP can significantly worsen cognitive decline, increasing the risk of transitioning from MCI to dementia 20-fold. Multimorbidity should be considered in dementia research and clinical studies.
© 2021 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.

Entities:  

Keywords:  cerebral multimorbidity; clinicopathological study; cognitive impairment; concomitant pathology; dementia; hyperphosphorylated tau; multiple pathologies; neuropathology

Mesh:

Substances:

Year:  2021        PMID: 33663011     DOI: 10.1002/alz.12291

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  13 in total

Review 1.  Recent update on the heterogeneity of the Alzheimer's disease spectrum.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2021-12-17       Impact factor: 3.575

Review 2.  Protein Aggregation Landscape in Neurodegenerative Diseases: Clinical Relevance and Future Applications.

Authors:  Niccolò Candelise; Silvia Scaricamazza; Illari Salvatori; Alberto Ferri; Cristiana Valle; Valeria Manganelli; Tina Garofalo; Maurizio Sorice; Roberta Misasi
Journal:  Int J Mol Sci       Date:  2021-06-02       Impact factor: 5.923

3.  Histopathological Analysis of Cerebrovascular Lesions Associated With Aging.

Authors:  Caroline Dallaire-Théroux; Stephan Saikali; Maxime Richer; Olivier Potvin; Simon Duchesne
Journal:  J Neuropathol Exp Neurol       Date:  2022-01-29       Impact factor: 3.685

4.  Mild behavioral impairment is associated with progression to Alzheimer's disease: A clinicopathological study.

Authors:  Myuri Ruthirakuhan; Zahinoor Ismail; Nathan Herrmann; Damien Gallagher; Krista L Lanctôt
Journal:  Alzheimers Dement       Date:  2022-02-01       Impact factor: 16.655

Review 5.  Synapses, Microglia, and Lipids in Alzheimer's Disease.

Authors:  Patrick J Paasila; Jason A Aramideh; Greg T Sutherland; Manuel B Graeber
Journal:  Front Neurosci       Date:  2022-01-12       Impact factor: 4.677

6.  Neurodegenerative brain changes are associated with area deprivation in the United Kingdom: findings from the Brains for Dementia Research study.

Authors:  Calum A Hamilton; Fiona E Matthews; Daniel Erskine; Johannes Attems; Alan J Thomas
Journal:  Acta Neuropathol Commun       Date:  2021-12-19       Impact factor: 7.801

7.  Neuronal-Derived EV Biomarkers Track Cognitive Decline in Alzheimer's Disease.

Authors:  Erden Eren; Jeannie-Marie Leoutsakos; Juan Troncoso; Constantine G Lyketsos; Esther S Oh; Dimitrios Kapogiannis
Journal:  Cells       Date:  2022-01-27       Impact factor: 7.666

8.  Application of predictive models in boosting power of Alzheimer's disease clinical trials: A post hoc analysis of phase 3 solanezumab trials.

Authors:  Ali Ezzati; Christos Davatzikos; David A Wolk; Charles B Hall; Christian Habeck; Richard B Lipton
Journal:  Alzheimers Dement (N Y)       Date:  2022-03-14

9.  Multimarker synaptic protein cerebrospinal fluid panels reflect TDP-43 pathology and cognitive performance in a pathological cohort of frontotemporal lobar degeneration.

Authors:  Alba Cervantes González; David J Irwin; Daniel Alcolea; Corey T McMillan; Alice Chen-Plotkin; David Wolk; Sònia Sirisi; Oriol Dols-Icardo; Marta Querol-Vilaseca; Ignacio Illán-Gala; Miguel Angel Santos-Santos; Juan Fortea; Edward B Lee; John Q Trojanowski; Murray Grossman; Alberto Lleó; Olivia Belbin
Journal:  Mol Neurodegener       Date:  2022-04-08       Impact factor: 14.195

10.  Cross-platform transcriptional profiling identifies common and distinct molecular pathologies in Lewy body diseases.

Authors:  Rahel Feleke; Regina H Reynolds; Amy M Smith; Michael R Johnson; Prashant K Srivastava; Mina Ryten; Bension Tilley; Sarah A Gagliano Taliun; John Hardy; Paul M Matthews; Steve Gentleman; David R Owen
Journal:  Acta Neuropathol       Date:  2021-07-26       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.